Rapid Rituximab Infusion at 90-minute Among Non-Hodgkin Lymphoma.

Trial Profile

Rapid Rituximab Infusion at 90-minute Among Non-Hodgkin Lymphoma.

Completed
Phase of Trial: Phase IV

Latest Information Update: 09 Dec 2013

At a glance

  • Drugs Rituximab (Primary)
  • Indications Non-Hodgkin's lymphoma
  • Focus Adverse reactions
  • Most Recent Events

    • 01 May 2012 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
    • 26 Mar 2012 Planned end date changed from 1 Jan 2013 to 1 May 2014 as reported by ClinicalTrials.gov.
    • 26 Mar 2012 Planned initiation date changed from 1 Jan 2012 to 1 May 2012 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top